Cases & Deals

  • Home
  • Practices
  • BioMarin advised on global intellectual property strategy for pharmaceutical products

Share

BioMarin advised on global intellectual property strategy for pharmaceutical products

November 2009

Client(s) BioMarin Pharmaceutical, Inc.

Jones Day advises BioMarin Pharmaceutical, Inc. with respect to adoption, clearance, registration and enforcement of trademarks and manages the Company's international trademark portfolio.

Contacts

Before sending, please note:

Information on www.jonesday.com is for general use and is not legal advice. The mailing of this email is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.